Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Cancer Res ; 59(16): 3875-9, 1999 Aug 15.
Article in English | MEDLINE | ID: mdl-10463573

ABSTRACT

Mutations in the adenomatous polyposis coli gene or activating mutations in the beta-catenin gene itself are thought to be responsible for the excessive beta-catenin signaling involved in intestinal carcinogenesis. We generated transgenic mice that expressed large amounts of a NH2-terminally truncated mutant beta-catenin (deltaN131beta-catenin) in the intestine. These mice had multifocal dysplastic lesions in the small intestine, reminiscent of the early lesions observed in the mouse models of familial adenomatous polyposis. The number of apoptotic cells in the villi of these transgenic mice was 3-4-fold higher than in nontransgenic mice. Expression of the truncated beta-catenin mutant in the kidney led to the development of severe polycystic kidney disease. Our findings support the concept that deregulation of the beta-catenin signaling pathway is the major oncogenic consequence of adenomatous polyposis coli mutations in intestinal neoplasia.


Subject(s)
Adenoma/genetics , Cytoskeletal Proteins/genetics , Gene Expression Regulation, Neoplastic , Intestinal Neoplasms/genetics , Mutation , Trans-Activators , Adenomatous Polyposis Coli/genetics , Animals , Cadherins/genetics , Intestinal Diseases/genetics , Mice , Mice, Transgenic , beta Catenin
SELECTION OF CITATIONS
SEARCH DETAIL
...